3,4-methylenedioxyamphetamine has been researched along with Hansen Disease in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correia, JC | 1 |
| Golay, A | 1 |
| Lachat, S | 1 |
| Singh, SB | 1 |
| Manandhar, V | 1 |
| Jha, N | 1 |
| Chappuis, F | 1 |
| Beran, D | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Hansen Disease
| Article | Year |
|---|---|
"If you will counsel properly with love, they will listen": A qualitative analysis of leprosy affected patients' educational needs and caregiver perceptions in Nepal.
Topics: Adolescent; Adult; Caregivers; Counseling; Female; Health Knowledge, Attitudes, Practice; Humans; Le | 2019 |